- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray introduces ddR Combi Trauma
Digital radiography pioneer Swissray is introducing the ddRCombi Trauma at the RSNA meeting. The system enables trauma and other emergency patients to be imaged from head to toe -- both AP and laterally -- easily and without being moved.
Digital radiography pioneer Swissray is introducing the ddRCombi Trauma at the RSNA meeting. The system enables trauma and other emergency patients to be imaged from head to toe - both AP and laterally - easily and without being moved.
The ddRCombi features a fixed table with elevating base, four-way floating top, and automatic detector positioning for cross-table imaging. The table can be controlled with a single button push on a wireless handheld remote control. Fully processed images are available in about five seconds.
"We're trying to build a broad line of products focused on key segments of the market," said Rex Harmon, vice president of marketing and public relations manager for Swissray. "The ddRCombi Trauma is important. The busiest component of a hospital that requires a high-volume, high-throughput radiography capability is an emergency room."
Swissray is also displaying several works-in-progress on the ddRCombi:
- dual-energy imaging, for separation of bone and soft-tissue image elements
- computer-aided diagnosis
- Osteocad, providing bone mineral analysis and measurements derived from a Swissray ddR-acquired digital hand radiograph
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
